Of the 35 inadequate regimens, monotherapy was indicated in five cases, always ensuring Pseudomonas aeruginosa coverage; on the other hand, combined therapy was indicated in 30 cases. In all the 30 cases of combined therapy, at least one antibiotic was active against P. aeruginosa and another was active against MRSA.
De las 35 pautas no adecuadas, en 5 casos se indicó monoterapia, siempre con antibióticos activos frente a Pseudomonas, y en 30 casos se indicó biterapia, en todos los casos con un antimicrobiano activo frente a P. aeruginosa y otro activo frente a SARM.